Thromboprophylaxis is a mainstay of treatment of hospitalized COVID-19 patients, due to the high occurrence of thrombotic events. This increases the risk of bleeding. However, data on …
M Umetsu, H Kanamori, K Murakami… - Annals of Vascular …, 2023 - jstage.jst.go.jp
Objectives: This study aimed to investigate the clinical features of arterial thrombosis and venous thromboembolism (VTE) in coronavirus disease 2019 (COVID-19). Methods: The …
A Poloni, G Casalini, G Pozza, A Giacomelli… - Medicina, 2024 - mdpi.com
Thromboprophylaxis/anticoagulation treatment is often required in hospitalized COVID-19 patients. We aimed to estimate the prevalence of major bleeding events in hospitalized …
EA Baybulatova, MS Chenkurov, EA Korovyakova… - …, 2023 - mdpi.com
Background: The coronavirus pandemic has led to the creation of clinical guidelines by a large number of professional medical communities. However, the quality and methodology …
Y Yamashita, T Kobayashi, M Mo - Journal of Atherosclerosis and …, 2023 - jstage.jst.go.jp
Abstract Coronavirus disease 2019 (COVID-19) has become a major health problem worldwide since 2020. Although the main pathophysiology of COVID-19 is a respiratory …
Abstract Introduction: Rectus sheath hematomas (RSHs) can occur from the rupture of the epigastric arteries, leading to blood accumulation within the rectus abdominis sheath …
Introduction: Novel coronavirus 19 disease (COVID-19) pandemic poses healthcare providers challenges in the endoscopic suite. It is unclear whether it affects the endoscopic …
ВД Аносов, СА Домрачев, СВ Овчинников… - Журнал им. НВ …, 2023 - cyberleninka.ru
В настоящее время проблема коронавирусной инфекции COVID-19 остается крайне актуальной, а вирус SARS-CoV-2 поражает в том числе желудочно-кишечный тракт, и в …
Background COVID-19 has been associated with a broad range of thromboembolic, ischemic, and hemorrhagic complications (coagulopathy complications). Most studies have …